Walmart’s 9% Checkout Shock

Welcome to LazyListen. This is The Daily Rip for today. S.

comparable sales, despite beating earnings estimates and raising its full-year outlook. The shares closed at about one hundred three dollars and eighty-four cents, on volume roughly four times the average, signaling a sharp selloff. Let’s break down what happened.

Walmart posted revenue of nearly one hundred eighty-eight billion dollars, up almost six percent year-over-year, and adjusted earnings per share of eighty-one cents, beating analyst expectations. So on the surface, the quarter looked solid. S.

comparable sales, which grew just two point six percent, falling short of the three point five percent analysts had forecast. This shortfall was partly due to government-mandated drug price caps, which created a nearly one percent drag on the health and wellness segment. While lowering drug prices is good news for consumers, it squeezed Walmart’s sales in that category, highlighting how policy changes can directly impact retail revenue.

The company’s management noted this headwind as a significant factor behind the softer sales growth. On the brighter side, Walmart’s global e-commerce sales surged twenty-three percent, reflecting strong momentum in its digital channels. Advertising revenue also jumped thirty-eight percent, showing that Walmart’s investments in its online platform and media business are paying off.

These areas are becoming increasingly important as Walmart competes with other retail giants and online marketplaces. Another positive was the receipt of a two point nine billion dollar tariff refund, which Walmart plans to use to lower prices starting this quarter. This move could help Walmart maintain its value proposition amid rising inflation and cost pressures.

However, the company also warned that rising fuel costs are expected to add over two billion dollars in expenses, which will offset some of those savings. So while there are pockets of relief, Walmart faces ongoing cost headwinds. Investors had Walmart trading at roughly forty times forward earnings going into the report, reflecting high expectations for near-perfect execution.

The combination of the sales miss and a cautious outlook for the third quarter was enough to send shares sharply lower. One market commentator noted that every few years, Walmart shares come at a discount worth considering, suggesting this pullback might present a buying opportunity for long-term investors. Turning now to other trending stocks, Moderna’s shares gave back some of Wednesday’s massive rally, dropping about twenty-four percent.

The biotech company had surged on news of a breakthrough in personalized cancer vaccines, with shares up over one hundred nine percent across five sessions. The market is now weighing whether upcoming Phase 3 trial results will justify that lofty valuation or if the recent rally pulled too much future success into the present. This kind of volatility is typical in biotech, where breakthroughs can drive huge swings but also come with significant clinical and regulatory risks.

In the industrials sector, Deere posted strong quarterly results, beating earnings estimates with just over five dollars per share and raising its profit outlook for 2026. Construction and forestry equipment sales jumped eighteen percent, and operating profit soared eighty-four percent. These numbers highlight Deere’s resilience amid a challenging macroeconomic environment.

However, the stock’s valuation remains a point of debate, as some investors question whether the strength in equipment sales can offset concerns about weakening demand for large machinery in the longer term. The agricultural recovery story is priced in to some extent, so investors are watching closely for signs of sustained momentum. In biotech, Iovance hit a 52-week high after UBS raised its price target from four to seven dollars, citing robust quarterly revenue of ninety-one million dollars and fifty-two percent sequential growth.

Shares closed near nine dollars, sparking a debate about whether the stock’s commercial momentum has already outpaced the analyst upgrade. This kind of valuation gap is common when stocks rally quickly on positive news, and investors will be watching for confirmation of sustained growth. Cryptocurrency-related stocks also made moves, with Marathon Digital Holdings up sixteen percent as Bitcoin climbed over six percent to around seventy-two thousand six hundred dollars.

This rally lifted other crypto proxies, including BitNile and Cipher Mining. Marathon’s stock benefited from both the Bitcoin price rebound and its strategic pivot toward artificial intelligence data centers. However, investors remain cautious, waiting to see if Bitcoin’s rebound and Marathon’s new focus will translate into sustained commercial success.

The crypto sector remains highly volatile and sensitive to broader market trends and regulatory developments. m. Eastern.

These reports provide early insight into economic activity and business sentiment for June, which can influence market direction. On the earnings front, the company's Wholesale Club and Ubiquiti will report before the market opens, while SCHMID Group will release results after the close. These reports will add more pieces to the market puzzle as investors navigate a complex landscape.

In summary, Walmart’s earnings highlight the challenges even retail giants face amid shifting government policies and rising costs. The company’s mixed results show how external factors like drug price caps and fuel expenses can impact performance, even when other segments like e-commerce and advertising are growing strongly. Meanwhile, strong results from Deere and Iovance demonstrate pockets of resilience in industrials and biotech, respectively.

Moderna and crypto stocks remind us that biotech breakthroughs and digital assets remain volatile but closely watched sectors. Tomorrow’s economic data and earnings will provide further clues about the health of the economy and corporate America as investors weigh these mixed signals. Thanks for listening.

Catch you next time on LazyListen.